These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27866948)

  • 21. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.
    Wilson DG; Poole WE; Chauhan SK; Rogers BA
    Bone Joint J; 2016 Aug; 98-B(8):1056-61. PubMed ID: 27482017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Validation of a Risk Stratification System for Pulmonary Embolism After Elective Primary Total Joint Arthroplasty.
    Bohl DD; Maltenfort MG; Huang R; Parvizi J; Lieberman JR; Della Valle CJ
    J Arthroplasty; 2016 Sep; 31(9 Suppl):187-91. PubMed ID: 27067463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effectiveness of a Risk Stratification Protocol for Thromboembolism Prophylaxis After Hip and Knee Arthroplasty.
    Nam D; Nunley RM; Johnson SR; Keeney JA; Clohisy JC; Barrack RL
    J Arthroplasty; 2016 Jun; 31(6):1299-1306. PubMed ID: 26777547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty.
    Johanson NA; Lachiewicz PF; Lieberman JR; Lotke PA; Parvizi J; Pellegrini V; Stringer TA; Tornetta P; Haralson RH; Watters WC
    J Am Acad Orthop Surg; 2009 Mar; 17(3):183-96. PubMed ID: 19264711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of oral direct factor Xa inhibiting anticoagulants in elective hip and knee arthroplasty: a meta-analysis of efficacy and safety profiles compared with those of low-molecular-weight heparins.
    As-Sultany M; Pagkalos J; Yeganeh S; Craigs CL; Korres N; West RM; Tsiridis E
    Curr Vasc Pharmacol; 2013 May; 11(3):366-75. PubMed ID: 23140527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
    Deirmengian GK; Heller S; Smith EB; Maltenfort M; Chen AF; Parvizi J
    J Arthroplasty; 2016 Oct; 31(10):2237-40. PubMed ID: 27118182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends of Venous Thromboembolism After Total Hip Arthroplasty in the United States: Analysis From 2011 to 2019.
    Agarwal AR; Das A; Harris A; Campbell JC; Golladay GJ; Thakkar SC
    J Am Acad Orthop Surg; 2023 Apr; 31(7):e376-e384. PubMed ID: 36727960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between use of direct oral anticoagulants and aspirin for risk of thromboembolism complications in patients undergoing total knee and hip arthroplasty: a systematic review and meta-analysis.
    Cai JY; Cui CM; Min JK; Cao YQ; Zhang LY
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6245-6259. PubMed ID: 34730204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
    J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
    Asopa V; Cobain W; Martin D; Keene G; Bauze A
    ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
    PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip Replacement: A Systematic Review and Network Meta-Analysis.
    Lewis S; Glen J; Dawoud D; Dias S; Cobb J; Griffin X; Reed M; Sharpin C; Stansby G; Barry P
    Value Health; 2019 Aug; 22(8):953-969. PubMed ID: 31426937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism debate in joint arthroplasty.
    Lieberman JR; Barnes CL; Lachiewicz PF; Hanssen AD; Clarke HD; Pellegrini VD
    J Bone Joint Surg Am; 2009 Aug; 91 Suppl 5():29-32. PubMed ID: 19648620
    [No Abstract]   [Full Text] [Related]  

  • 35. Is Aspirin as Effective as the Newer Direct Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Total Hip and Knee Arthroplasty? An Analysis From the National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man.
    Matharu GS; Garriga C; Whitehouse MR; Rangan A; Judge A
    J Arthroplasty; 2020 Sep; 35(9):2631-2639.e6. PubMed ID: 32532481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].
    Tian H; Song F; Zhang K; Liu Y
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3349-52. PubMed ID: 18478950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry.
    Jameson SS; Charman SC; Gregg PJ; Reed MR; van der Meulen JH
    J Bone Joint Surg Br; 2011 Nov; 93(11):1465-70. PubMed ID: 22058295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New oral anticoagulants for thromboprophylaxis after total hip or knee arthroplasty.
    Friedman RJ
    Orthopedics; 2009 Dec; 32(12 Suppl):79-84. PubMed ID: 20201481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
    Ma G; Zhang R; Wu X; Wang D; Ying K
    Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effective prophylaxis against venous thromboembolism after total joint arthroplasty: warfarin versus aspirin.
    Mostafavi Tabatabaee R; Rasouli MR; Maltenfort MG; Parvizi J
    J Arthroplasty; 2015 Feb; 30(2):159-64. PubMed ID: 25534862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.